{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Calbindine-2 : Questions médicales les plus fréquentes",
"headline": "Calbindine-2 : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Calbindine-2 : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-06-21",
"dateModified": "2025-03-18",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Calbindine-2"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Calbindines",
"url": "https://questionsmedicales.fr/mesh/D064026",
"about": {
"@type": "MedicalCondition",
"name": "Calbindines",
"code": {
"@type": "MedicalCode",
"code": "D064026",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.157.125.090"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Calbindine-2",
"alternateName": "Calbindin 2",
"code": {
"@type": "MedicalCode",
"code": "D064032",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Eui-Man Jung",
"url": "https://questionsmedicales.fr/author/Eui-Man%20Jung",
"affiliation": {
"@type": "Organization",
"name": "Laboratory of Veterinary Biochemistry and Molecular Biology, Veterinary Medical Center and College of Veterinary Medicine, Chungbuk National University, Cheongju, Chungbuk, Republic of Korea."
}
},
{
"@type": "Person",
"name": "Yeong-Min Yoo",
"url": "https://questionsmedicales.fr/author/Yeong-Min%20Yoo",
"affiliation": {
"@type": "Organization",
"name": "Laboratory of Veterinary Biochemistry and Molecular Biology, Veterinary Medical Center and College of Veterinary Medicine, Chungbuk National University, Cheongju, Chungbuk, Republic of Korea."
}
},
{
"@type": "Person",
"name": "Eui-Bae Jeung",
"url": "https://questionsmedicales.fr/author/Eui-Bae%20Jeung",
"affiliation": {
"@type": "Organization",
"name": "Laboratory of Veterinary Biochemistry and Molecular Biology, Veterinary Medical Center and College of Veterinary Medicine, Chungbuk National University, Cheongju, Chungbuk, Republic of Korea, ebjeung@chungbuk.ac.kr."
}
},
{
"@type": "Person",
"name": "Seon Young Park",
"url": "https://questionsmedicales.fr/author/Seon%20Young%20Park",
"affiliation": {
"@type": "Organization",
"name": "Laboratory of Veterinary Biochemistry and Molecular Biology, Veterinary Medical Center and College of Veterinary Medicine, Chungbuk National University, Cheongju, Chungbuk, Republic of Korea."
}
},
{
"@type": "Person",
"name": "Changhwan Ahn",
"url": "https://questionsmedicales.fr/author/Changhwan%20Ahn",
"affiliation": {
"@type": "Organization",
"name": "Laboratory of Veterinary Biochemistry and Molecular Biology, Veterinary Medical Center and College of Veterinary Medicine, Chungbuk National University, Cheongju, Chungbuk, Republic of Korea."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "The Montreal Cognitive Assessment Test (MoCA) as a screening tool for cognitive dysfunction in fibromyalgia.",
"datePublished": "2022-06-08",
"url": "https://questionsmedicales.fr/article/35699063",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.55563/clinexprheumatol/3yxu6p"
}
},
{
"@type": "ScholarlyArticle",
"name": "The Spectrum of Cognitive Dysfunction in Amyotrophic Lateral Sclerosis: An Update.",
"datePublished": "2023-09-27",
"url": "https://questionsmedicales.fr/article/37834094",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijms241914647"
}
},
{
"@type": "ScholarlyArticle",
"name": "The Confusion Surrounding Androgen Deprivation Therapy and Cognitive Dysfunction.",
"datePublished": "2023-03-31",
"url": "https://questionsmedicales.fr/article/37005166",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.euf.2023.03.015"
}
},
{
"@type": "ScholarlyArticle",
"name": "Neuroanatomical Correlates of Cognitive Dysfunction in 22q11.2 Deletion Syndrome.",
"datePublished": "2024-03-30",
"url": "https://questionsmedicales.fr/article/38674375",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/genes15040440"
}
},
{
"@type": "ScholarlyArticle",
"name": "Sex differences in the effects of sleep disorders on cognitive dysfunction.",
"datePublished": "2023-01-27",
"url": "https://questionsmedicales.fr/article/36716906",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.neubiorev.2023.105067"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Acides aminés, peptides et protéines",
"item": "https://questionsmedicales.fr/mesh/D000602"
},
{
"@type": "ListItem",
"position": 3,
"name": "Protéines",
"item": "https://questionsmedicales.fr/mesh/D011506"
},
{
"@type": "ListItem",
"position": 4,
"name": "Protéines de transport",
"item": "https://questionsmedicales.fr/mesh/D002352"
},
{
"@type": "ListItem",
"position": 5,
"name": "Protéines de liaison au calcium",
"item": "https://questionsmedicales.fr/mesh/D002135"
},
{
"@type": "ListItem",
"position": 6,
"name": "Calbindines",
"item": "https://questionsmedicales.fr/mesh/D064026"
},
{
"@type": "ListItem",
"position": 7,
"name": "Calbindine-2",
"item": "https://questionsmedicales.fr/mesh/D064032"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Calbindine-2 - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Calbindine-2",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-14",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Calbindine-2",
"description": "Comment diagnostiquer une carence en calbindine-2 ?\nQuels examens sont utilisés pour évaluer la calbindine-2 ?\nLa calbindine-2 est-elle mesurable dans le sang ?\nQuels symptômes peuvent indiquer un problème avec la calbindine-2 ?\nY a-t-il des marqueurs spécifiques pour la calbindine-2 ?",
"url": "https://questionsmedicales.fr/mesh/D064032?mesh_terms=Cognitive+Dysfunction&page=2#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Calbindine-2",
"description": "Quels sont les symptômes d'une déficience en calbindine-2 ?\nLa calbindine-2 affecte-t-elle le système nerveux ?\nDes douleurs musculaires peuvent-elles être liées à la calbindine-2 ?\nLa fatigue est-elle un symptôme associé à la calbindine-2 ?\nPeut-on observer des troubles cognitifs liés à la calbindine-2 ?",
"url": "https://questionsmedicales.fr/mesh/D064032?mesh_terms=Cognitive+Dysfunction&page=2#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Calbindine-2",
"description": "Comment prévenir une carence en calbindine-2 ?\nLes suppléments de calcium sont-ils nécessaires ?\nY a-t-il des groupes à risque pour la calbindine-2 ?\nL'exposition au soleil est-elle importante ?\nDes tests réguliers sont-ils conseillés ?",
"url": "https://questionsmedicales.fr/mesh/D064032?mesh_terms=Cognitive+Dysfunction&page=2#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Calbindine-2",
"description": "Comment traiter une carence en calbindine-2 ?\nY a-t-il des médicaments pour réguler la calbindine-2 ?\nLa physiothérapie aide-t-elle en cas de dysfonction de la calbindine-2 ?\nDes changements alimentaires peuvent-ils aider ?\nLes exercices physiques sont-ils bénéfiques ?",
"url": "https://questionsmedicales.fr/mesh/D064032?mesh_terms=Cognitive+Dysfunction&page=2#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Calbindine-2",
"description": "Quelles complications peuvent survenir avec une carence en calbindine-2 ?\nLa calbindine-2 est-elle liée à des maladies chroniques ?\nDes troubles de l'humeur peuvent-ils être liés à la calbindine-2 ?\nLa calbindine-2 influence-t-elle le développement cognitif ?\nY a-t-il un risque accru de chutes ?",
"url": "https://questionsmedicales.fr/mesh/D064032?mesh_terms=Cognitive+Dysfunction&page=2#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Calbindine-2",
"description": "Quels facteurs augmentent le risque de carence en calbindine-2 ?\nLes troubles métaboliques sont-ils un facteur de risque ?\nLe mode de vie sédentaire influence-t-il la calbindine-2 ?\nLes régimes restrictifs sont-ils risqués ?\nLes antécédents familiaux jouent-ils un rôle ?",
"url": "https://questionsmedicales.fr/mesh/D064032?mesh_terms=Cognitive+Dysfunction&page=2#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une carence en calbindine-2 ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests sanguins et des biopsies musculaires peuvent aider à évaluer les niveaux de calbindine-2."
}
},
{
"@type": "Question",
"name": "Quels examens sont utilisés pour évaluer la calbindine-2 ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'électrophorèse des protéines et l'immunohistochimie sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "La calbindine-2 est-elle mesurable dans le sang ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, la calbindine-2 est principalement présente dans les tissus, pas dans le sang."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent indiquer un problème avec la calbindine-2 ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des troubles neurologiques ou musculaires peuvent suggérer un dysfonctionnement de la calbindine-2."
}
},
{
"@type": "Question",
"name": "Y a-t-il des marqueurs spécifiques pour la calbindine-2 ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des marqueurs comme la calmoduline peuvent être évalués en relation avec la calbindine-2."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une déficience en calbindine-2 ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des spasmes musculaires, des tremblements et des troubles de la coordination."
}
},
{
"@type": "Question",
"name": "La calbindine-2 affecte-t-elle le système nerveux ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle joue un rôle crucial dans la transmission synaptique et la plasticité neuronale."
}
},
{
"@type": "Question",
"name": "Des douleurs musculaires peuvent-elles être liées à la calbindine-2 ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une dysfonction de la calbindine-2 peut entraîner des douleurs musculaires et des crampes."
}
},
{
"@type": "Question",
"name": "La fatigue est-elle un symptôme associé à la calbindine-2 ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une fatigue excessive peut résulter d'une mauvaise régulation du calcium par la calbindine-2."
}
},
{
"@type": "Question",
"name": "Peut-on observer des troubles cognitifs liés à la calbindine-2 ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles cognitifs peuvent survenir en raison de l'implication de la calbindine-2 dans le cerveau."
}
},
{
"@type": "Question",
"name": "Comment prévenir une carence en calbindine-2 ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée et des contrôles réguliers de la santé peuvent aider."
}
},
{
"@type": "Question",
"name": "Les suppléments de calcium sont-ils nécessaires ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent être recommandés, surtout pour les personnes à risque de carence."
}
},
{
"@type": "Question",
"name": "Y a-t-il des groupes à risque pour la calbindine-2 ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les personnes âgées et celles avec des troubles métaboliques sont plus à risque."
}
},
{
"@type": "Question",
"name": "L'exposition au soleil est-elle importante ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition au soleil aide à la synthèse de la vitamine D, essentielle pour la calbindine-2."
}
},
{
"@type": "Question",
"name": "Des tests réguliers sont-ils conseillés ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des tests réguliers peuvent aider à détecter précocement des anomalies."
}
},
{
"@type": "Question",
"name": "Comment traiter une carence en calbindine-2 ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement peut inclure des suppléments de calcium et des thérapies ciblées."
}
},
{
"@type": "Question",
"name": "Y a-t-il des médicaments pour réguler la calbindine-2 ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Actuellement, il n'existe pas de médicaments spécifiques pour la calbindine-2."
}
},
{
"@type": "Question",
"name": "La physiothérapie aide-t-elle en cas de dysfonction de la calbindine-2 ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la physiothérapie peut améliorer la force musculaire et la coordination."
}
},
{
"@type": "Question",
"name": "Des changements alimentaires peuvent-ils aider ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation riche en calcium et en vitamine D peut soutenir la fonction de la calbindine-2."
}
},
{
"@type": "Question",
"name": "Les exercices physiques sont-ils bénéfiques ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des exercices réguliers peuvent améliorer la santé musculaire et nerveuse."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec une carence en calbindine-2 ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications neurologiques et musculaires graves peuvent se développer."
}
},
{
"@type": "Question",
"name": "La calbindine-2 est-elle liée à des maladies chroniques ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des maladies comme l'ostéoporose peuvent être exacerbées par une carence en calbindine-2."
}
},
{
"@type": "Question",
"name": "Des troubles de l'humeur peuvent-ils être liés à la calbindine-2 ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des déséquilibres de calcium peuvent affecter l'humeur et le comportement."
}
},
{
"@type": "Question",
"name": "La calbindine-2 influence-t-elle le développement cognitif ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une déficience peut nuire au développement cognitif, surtout chez les enfants."
}
},
{
"@type": "Question",
"name": "Y a-t-il un risque accru de chutes ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une faiblesse musculaire due à une carence en calbindine-2 augmente le risque de chutes."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque de carence en calbindine-2 ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'âge avancé, une mauvaise alimentation et certaines maladies augmentent le risque."
}
},
{
"@type": "Question",
"name": "Les troubles métaboliques sont-ils un facteur de risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles comme le diabète peuvent affecter les niveaux de calbindine-2."
}
},
{
"@type": "Question",
"name": "Le mode de vie sédentaire influence-t-il la calbindine-2 ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sédentaire peut contribuer à une faiblesse musculaire et à des carences."
}
},
{
"@type": "Question",
"name": "Les régimes restrictifs sont-ils risqués ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les régimes restrictifs peuvent entraîner des carences en nutriments essentiels, y compris le calcium."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux jouent-ils un rôle ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux de troubles musculaires ou neurologiques peuvent augmenter le risque."
}
}
]
}
]
}
Cognitive dysfunction is one of the criteria for the diagnosis of fibromyalgia (FM) and is typically based on self-report questionnaires such as the Symptom Severity Scale. However, recent studies hav...
Sixty-two FM patients (55 women, 7 men, mean age = 46.17 years, sd=12.56) were administered the MoCA and a computerised cognitive assessment battery. FM symptoms were assessed on the Fibromyalgia Impa...
Moderate positive correlations were found between the MoCA and the computerised cognitive scores as follows: Global Cognitive Score (r=0.493**, p=0.00), Memory Index Score (r= 0.384**, p=0.002), Execu...
The MoCA is an acceptable cognitive screening test for the cognitive evaluation of FM patients....
Cognitive dysfunction is an important non-motor symptom in amyotrophic lateral sclerosis (ALS) that has a negative impact on survival and caregiver burden. It shows a wide spectrum ranging from subjec...
There are varied associations that have been identified between the use of androgen deprivation therapy (ADT) and the development of cognitive decline. We highlight the first studies to evaluate chron...
22q11.2 Deletion Syndrome (22q11.2DS), the most common chromosomal microdeletion, presents as a heterogeneous phenotype characterized by an array of anatomical, behavioral, and cognitive abnormalities...
Sleep is an essential physiological function that sustains human life. Sleep disorders involve problems with the quality, duration, and abnormal behaviour of sleep. Insomnia is the most common sleep d...
Previous studies have shown that multimorbidity is a risk factor for cognitive dysfunction (CD).Type 2 diabetes mellitus (T2DM) and hypertension (HT) are very common risk factors.The association betwe...
To evaluate the association between multimorbidity due to T2DM and HT with CD among adults ≥50 years in Tumbes....
A secondary analysis of a population-based cross-sectional study was conducted. The exposure variable was the presence of both T2DM and HT, split into categories: without HT or T2DM, only T2DM, only H...
688 participants were analyzed. The prevalence of CD was 39.1%. There was a 56.1% of participants without TDM2 nor HT, 8.3% with T2DM, 28.9% with HT and 6.7% with both diseases. A significant associat...
There is association between the morbidity of T2DM and HT, and CD among adults ≥50 years of age in Tumbes. Education was an effect modifier of the association between HT and T2DM on the presence of CD...
Type 2 diabetes (T2DM) is a well known risk factor for Alzheimer's disease. Mitochondria are the center of intracellular energy metabolism and the main source of reactive oxygen species. Mitochondrial...
This review provides an overview of obsessive-compulsive disorder (OCD) symptoms, including the four partially distinct subtypes of the disorder, current diagnostic criteria, and common comorbidities....
This review study was conducted by library method....
We show how dysfunction in cortico-striato-thalamo-cortical (CSTC) circuits may underpin symptoms; and shed light on the putative neurochemistry within these loops such as the role of serotonin, dopam...
In brief, research questions we shed light on include (1) what are the symptoms in OCD; (2) what is the etiology of the disorder and do existing models explain OCD; and (3) what are key cognitive defi...
Systemic lupus erythematosus (SLE) is a chronic autoimmune disease, in which cognitive dysfunction is common, but poorly understood. This study aims to characterize the prevalence and patterns of cogn...
SLE patients (...
The SLE group performed significantly worse than healthy controls on every cognitive test. The largest differences were in the domains of verbal fluency, working memory and attention, while fine motor...
Cognitive dysfunction is common in SLE but markedly heterogeneous across both cognitive domains and across the SLE group. Cluster analysis supports the use of a binary definition of cognitive dysfunct...
A growing body of literature suggests the important role of the thalamus in cognition and neurodegenerative diseases. This study aims to elucidate whether the preoperative thalamic volume is associate...